Quantbot Technologies LP Buys Shares of 104,657 Acadia Healthcare Company, Inc. $ACHC

Key Points

• Quantbot Technologies LP acquired 104,657 shares of Acadia Healthcare Company, Inc., valued at approximately $3.17 million, increasing its stake to about 0.11% as of the latest reporting period.
• Acadia Healthcare reported a quarterly earnings per share of $0.83, surpassing analysts' estimates, with revenues of $869.23 million, a 9.2% year-over-year increase.
• Analyst ratings show a mix of opinions, with Barclays reducing its price target to $20 and a consensus rating of "Moderate Buy" among nine analysts.

Quantbot Technologies LP acquired a new stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 104,657 shares of the company's stock, valued at approximately $3,173,000. Quantbot Technologies LP owned about 0.11% of Acadia Healthcare at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of ACHC. Russell Investments Group Ltd. increased its stake in shares of Acadia Healthcare by 21.4% during the 4th quarter. Russell Investments Group Ltd. now owns 18,421 shares of the company's stock valued at $730,000 after acquiring an additional 3,248 shares during the last quarter. Raymond James Financial Inc. acquired a new position in shares of Acadia Healthcare during the 4th quarter valued at about $5,134,000. Barclays PLC increased its stake in shares of Acadia Healthcare by 32.9% during the 4th quarter. Barclays PLC now owns 146,208 shares of the company's stock valued at $5,796,000 after acquiring an additional 36,189 shares during the last quarter. Mariner LLC boosted its holdings in Acadia Healthcare by 88.7% in the fourth quarter. Mariner LLC now owns 16,638 shares of the company's stock valued at $660,000 after acquiring an additional 7,823 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its holdings in Acadia Healthcare by 18.0% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,182,729 shares of the company's stock valued at $126,189,000 after acquiring an additional 486,395 shares during the last quarter.

Acadia Healthcare Stock Down 1.9%

Shares of NASDAQ ACHC traded down $0.4350 during midday trading on Monday, reaching $22.0050. 349,269 shares of the company's stock were exchanged, compared to its average volume of 2,192,186. Acadia Healthcare Company, Inc. has a 52-week low of $17.13 and a 52-week high of $82.40. The stock has a market capitalization of $2.03 billion, a PE ratio of 14.58, a price-to-earnings-growth ratio of 4.42 and a beta of 0.88. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.32 and a current ratio of 1.32. The business's fifty day moving average price is $21.92 and its two-hundred day moving average price is $26.01.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $0.83 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.71 by $0.12. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.The business had revenue of $869.23 million for the quarter, compared to analyst estimates of $839.59 million. During the same period in the previous year, the company earned $0.91 earnings per share. The company's revenue for the quarter was up 9.2% compared to the same quarter last year. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. Analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on ACHC shares. KeyCorp reduced their target price on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a report on Wednesday, May 14th. Royal Bank Of Canada dropped their target price on shares of Acadia Healthcare from $43.00 to $28.00 and set an "outperform" rating for the company in a research report on Wednesday, August 13th. Stephens raised shares of Acadia Healthcare to a "hold" rating in a research report on Monday, June 2nd. Barclays dropped their target price on shares of Acadia Healthcare from $28.00 to $20.00 and set an "equal weight" rating for the company in a research report on Thursday, August 7th. Finally, Guggenheim dropped their target price on shares of Acadia Healthcare from $36.00 to $29.00 and set a "buy" rating for the company in a research report on Thursday, August 7th. Nine investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, Acadia Healthcare currently has a consensus rating of "Moderate Buy" and a consensus target price of $40.77.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.